Phosphoproteomic analysis of the human pituitary

被引：48

作者：

Beranova-Giorgianni S. ^{[1
,2
,3
]}

Zhao Y. ^{[2
]}

Desiderio D.M. ^{[3
]}

Giorgianni F. ^{[1
,3
]}

机构：

[1] Charles B. Stout Neuroscience Mass Spectrometry Laboratory, The University of Tennessee Health Science Center, Memphis

[2] Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis

[3] Department of Neurology, The University of Tennessee Health Science Center, Memphis

来源：

Pituitary | 2006年 / 9卷 / 2期

基金：

美国国家卫生研究院;

关键词：

Human pituitary tissue; Isoelectric focusing; Mass spectrometry; Phosphoproteome;

D O I：

10.1007/s11102-006-8916-x

中图分类号：

学科分类号：

摘要：

The pituitary is the central endocrine gland that regulates the functions of various target organs in the human body. Because of the pivotal regulatory role of the pituitary, it is essential to define on a global scale the components of the pituitary protein machinery, including a comprehensive characterization of the post-translational modifications of the pituitary proteins. Of particular interest is the examination of the phosphorylation status of the pituitary in health and disease. Towards the goal of global profiling of pituitary protein phosphorylation, we report here the application of the in-gel IEF-LC-MS/ MS approach to the study of the pituitary phosphoproteome. The analytical strategy combined isoelectric focusing in immobilized pH gradient strips with immobilized metal ion affinity chromatography and mass spectrometry. With this method, a total of 50 phosphorylation sites were characterized in 26 proteins. Because the investigation involved primary tissue, the findings provide a direct glimpse into the phosphoprotein machinery operating within the human pituitary tissue microenvironment. © Springer Science + Business Media, LLC 2006.

引用

页码：109 / 120

页数：11

共 50 条

[1]

Asa S.L., Ezzat S., The pathogenesis of pituitary tumours, Nat Rev Cancer, 2, pp. 836-849, (2002)

[2]

Heaney A.P., Melmed S., Molecular targets in pituitary tumours, Nat Rev Cancer, 4, pp. 285-295, (2004)

[3]

Noble M.E., Endicott J.A., Johnson L.N., Protein kinase inhibitors: Insights into drug design from structure, Sci., 303, pp. 1800-1805, (2004)

[4]

Beranova-Giorgianni S., Giorgianni F., Desiderio D.M., Analysis of the proteome in the human pituitary, Proteomics, 2, pp. 534-542, (2002)

[5]

Zhan X., Desiderio D.M., A reference map of a human pituitary adenoma proteome, Proteomics, 3, pp. 699-713, (2003)

[6]

Zhan X., Evans C.O., Oyesiku N.M., Desiderio D.M., Proteomics, transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas, Pituitary, 6, pp. 189-202, (2003)

[7]

Giorgianni F., Beranova-Giorgianni S., Desiderio D.M., Identification and characterization of phosphorylated proteins in the human pituitary, Proteomics, 4, pp. 587-598, (2004)

[8]

Giorgianni F., Desiderio D.M., Beranova-Giorgianni S., Proteome analysis using isoelectric focusing in immobilized pH gradient gels followed by mass spectrometry, Electrophoresis, 24, pp. 253-259, (2003)

[9]

Zhao Y., Giorgianni F., Desiderio D.M., Fang B., Beranova-Giorgianni S., Toward a global analysis of the human pituitary proteome by multiple gel-based technology, Anal Chem, 77, pp. 5324-5331, (2005)

[10]

Gatlin C.L., Kleemann G.R., Hays L.G., Link A.J., Yates III J.R., Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry, Anal Biochem, 263, pp. 93-101, (1998)

← 1 2 3 4 5 →